Share Name Share Symbol Market Type Share ISIN Share Description
Assura Group LSE:AGR London Ordinary Share GB00BVGBWW93 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.60p -2.86% 54.30p 54.10p 54.20p 55.90p 54.10p 55.90p 1,459,846 16:35:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food & Drug Retailers 83.5 71.8 3.7 14.7 1,294.04

Assura Share Discussion Threads

Showing 776 to 799 of 800 messages
Chat Pages: 32  31  30  29  28  27  26  25  24  23  22  21  Older
DateSubjectAuthorDiscuss
06/9/2018
10:24
The annual report is worth a look. Check how many pages there are justifying exec remuneration and then compare against amount of comment on shareholder return.
aa29
03/9/2018
18:55
EI - right, thanks. When I bought here, it was in preference to the other two companies as I thought less risky. But that was a while ago.
jonwig
03/9/2018
18:52
Jon, my comment was re the ..bond proxy post. To be honest I don't have enough interest in this sub sector to investigate a comparative analysis. Luck with your holding, and my view is often on the cautious side in fairness.
essentialinvestor
03/9/2018
18:46
EI - okay, I've looked this point up in the latest fundraising circular from November 2017. In the risk factors, p21 (pdf p23) they have: The Group’s development pipeline may also be exposed to cost overruns, completion delays, planning difficulties and financing shortfalls, in which case the Group may need to commit additional funding to the relevant development than it had originally planned from its existing cash resources. Furthermore, while the Group’s policy is to engage in developments that are substantially pre-let with fixed price build contracts (or contracts with a price ceiling) in place at their inception, occasionally some of the Group’s developments may not be fully pre-let. In such circumstances, if the Group were unable to find tenants for any surplus space, the Group could be left with unutilised space in buildings which may have limited application to alternative uses, thereby negatively impacting the Group’s return on its development investment. The underlined bit suggests the situation here isn't really so serious. But, given that it is building new health centres, it is acting at both ends of the infrastructure sector: construction (riskier) and rental/maintenance (safer). My question to you would be: is this situation any different from that of PHP and MXF, the other two sector players? And are these two better-performing, more or less risky (look at gearing)?
jonwig
03/9/2018
18:11
This may be higher up the 'risk' scale than consensus perception. Assura assume liability for construction costs, what protection do they have against cost overuns..
essentialinvestor
03/9/2018
16:46
One suggestion is that the current decline may be due to the summer market - where lower volumes may lead to anomalies. Companies must inform the market if there is a real issue of concern. Happy to collect the quarterly dividends. z
zeppo
03/9/2018
15:55
I had some PHP but sold out as I thought they were overvalued. I appreciate AGR is a bit of a bond proxy but the nav has been improving steadily and yet the share price still declines. FWIW I'm happy to top up at this level given the healthy pipeline and progressive dividend.
jimbo3352
03/9/2018
15:20
PHP have performed a bit better and have a bigger premium to NAV but poorer dividend cover. I hold them too but much less than my Assura holding. I personally prefer Assura but the market obviously doesn't.
winsome
03/9/2018
15:12
Yes, good summary jonwig. AGR make up nearly 10% of my portfolio. Bought in just over 30p and been disappointing last 3 years but no worse that than the FT350 performance. I feel it will settle around 52p level and I will top up at that point for the 4.5% yield, if only because I can't find much value elsewhere at the moment.
winsome
30/8/2018
15:51
Thank you for your excellent analysis of the situation! I can move from panic mode to calm. z
zeppo
30/8/2018
15:36
At 31 March, the nav (EPRA) was 52.4p, so there's still a premium there. Many property sectors are moving to discounts with only industrial estates commanding a premium. If you invest in property shares, you need to follow relative sentiment (retail? - right!), and start to get concerned only when a discount appears. This could happen if AGR were over-geared (it isn't) or there was political risk (I don't really see it) or they said discouraging things (they don't). It does look as though they might find it hard to do an equity fundraising since you need a decent gap between nav and sp, but at the moment there's no sign of that.
jonwig
30/8/2018
14:43
stupidboypike Don't tell him Pike! Property out of favour? Short term outlook not too hopeful. Hope we can continue to cry all the way to the bank with the quarterly dividends. z
zeppo
30/8/2018
12:47
Don't know but I will add if it drops much further, great value bond as far as I'm concerned.
stupidboypike
30/8/2018
12:45
Dire! Dire! Dire! Any explanations? z
zeppo
04/7/2018
10:03
My adviser regards it as an income stock. Personally I am very disappointed at the share price since the 57p Rights. Will next week's AGM publish a positive announcement. Progress on new property deals? z
zeppo
15/6/2018
23:39
I'm in. Regarding it as a high yield bond.
grahamite2
14/6/2018
17:43
Thank you jonwig! Some reassurance then. 51%? institutional holders. Hope they continue to support this. z
zeppo
14/6/2018
17:11
Well, it did go xd this morning (0.655p)!!
jonwig
14/6/2018
17:03
Below the minimally discounted rights price. Bitterly disappointing at this stage. z
zeppo
12/6/2018
09:07
Jimbo3352 Thank you! z
zeppo
11/6/2018
14:48
"Can healthcare property boom save the NHS?" in the business section Rhiannon Curry
jimbo3352
11/6/2018
12:34
jimbo3352 I have only found "Carebots" could take over from NHS medics to save £13bn a year. online. What is the heading for the article? The journalist/s? z
zeppo
11/6/2018
10:11
Interesting article in the Daily Telegraph today featuring comments by Jonathan Murphy and Harry Hyams on the provision of purpose built GP premises
jimbo3352
01/6/2018
16:36
winsome - thanks. I think the drop in the share price after the results is connected in some way with the results from MedicX [MXF] and their plans. But I haven't looked much into this so can't say any more. The Assura statement and numbers were bang on track - I suppose it might be a bit vulnerable owing tho the NAV premium. Anyway, I'm relaxed.
jonwig
Chat Pages: 32  31  30  29  28  27  26  25  24  23  22  21  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20180926 01:21:47